Literature DB >> 31744819

Molecular Profiles of Matched Primary and Metastatic Tumor Samples Support a Linear Evolutionary Model of Breast Cancer.

Runpu Chen1, Steve Goodison2, Yijun Sun3,4,5.   

Abstract

The interpretation of accumulating genomic data with respect to tumor evolution and cancer progression requires integrated models. We developed a computational approach that enables the construction of disease progression models using static sample data. Application to breast cancer data revealed a linear, branching evolutionary model with two distinct trajectories for malignant progression. Here, we used the progression model as a foundation to investigate the relationships between matched primary and metastasis breast tumor samples. Mapping paired data onto the model confirmed that molecular breast cancer subtypes can shift during progression and supported directional tumor evolution through luminal subtypes to increasingly malignant states. Cancer progression modeling through the analysis of available static samples represents a promising breakthrough. Further refinement of a roadmap of breast cancer progression will facilitate the development of improved cancer diagnostics, prognostics, and targeted therapeutics. SIGNIFICANCE: Analysis of matched primary and metastatic tumor samples supports a unidirectional, linear cancer evolution process and sheds light on longstanding issues regarding the origins of molecular subtypes and their progression relationships. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2019        PMID: 31744819      PMCID: PMC8978345          DOI: 10.1158/0008-5472.CAN-19-2296

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  18 in total

1.  Adjusting batch effects in microarray expression data using empirical Bayes methods.

Authors:  W Evan Johnson; Cheng Li; Ariel Rabinovic
Journal:  Biostatistics       Date:  2006-04-21       Impact factor: 5.899

2.  A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers.

Authors:  Ashton C Berger; Anil Korkut; Rupa S Kanchi; Apurva M Hegde; Walter Lenoir; Wenbin Liu; Yuexin Liu; Huihui Fan; Hui Shen; Visweswaran Ravikumar; Arvind Rao; Andre Schultz; Xubin Li; Pavel Sumazin; Cecilia Williams; Pieter Mestdagh; Preethi H Gunaratne; Christina Yau; Reanne Bowlby; A Gordon Robertson; Daniel G Tiezzi; Chen Wang; Andrew D Cherniack; Andrew K Godwin; Nicole M Kuderer; Janet S Rader; Rosemary E Zuna; Anil K Sood; Alexander J Lazar; Akinyemi I Ojesina; Clement Adebamowo; Sally N Adebamowo; Keith A Baggerly; Ting-Wen Chen; Hua-Sheng Chiu; Steve Lefever; Liang Liu; Karen MacKenzie; Sandra Orsulic; Jason Roszik; Carl Simon Shelley; Qianqian Song; Christopher P Vellano; Nicolas Wentzensen; John N Weinstein; Gordon B Mills; Douglas A Levine; Rehan Akbani
Journal:  Cancer Cell       Date:  2018-04-02       Impact factor: 31.743

3.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.

Authors:  T Sørlie; C M Perou; R Tibshirani; T Aas; S Geisler; H Johnsen; T Hastie; M B Eisen; M van de Rijn; S S Jeffrey; T Thorsen; H Quist; J C Matese; P O Brown; D Botstein; P E Lønning; A L Børresen-Dale
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

4.  Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer.

Authors:  Juan M Cejalvo; Eduardo Martínez de Dueñas; Patricia Galván; Susana García-Recio; Octavio Burgués Gasión; Laia Paré; Silvia Antolín; Rosella Martinello; Isabel Blancas; Barbara Adamo; Ángel Guerrero-Zotano; Montserrat Muñoz; Paolo Nucíforo; María Vidal; Ramón M Pérez; José I Chacón López-Muniz; Rosalía Caballero; Vicente Peg; Eva Carrasco; Federico Rojo; Charles M Perou; Javier Cortés; Vincenzo Adamo; Joan Albanell; Roger R Gomis; Ana Lluch; Aleix Prat
Journal:  Cancer Res       Date:  2017-03-01       Impact factor: 12.701

5.  Computational approach for deriving cancer progression roadmaps from static sample data.

Authors:  Yijun Sun; Jin Yao; Le Yang; Runpu Chen; Norma J Nowak; Steve Goodison
Journal:  Nucleic Acids Res       Date:  2017-05-19       Impact factor: 16.971

6.  The clonal evolution of tumor cell populations.

Authors:  P C Nowell
Journal:  Science       Date:  1976-10-01       Impact factor: 47.728

Review 7.  Tumor evolution: Linear, branching, neutral or punctuated?

Authors:  Alexander Davis; Ruli Gao; Nicholas Navin
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-01-19       Impact factor: 10.680

8.  Supervised risk predictor of breast cancer based on intrinsic subtypes.

Authors:  Joel S Parker; Michael Mullins; Maggie C U Cheang; Samuel Leung; David Voduc; Tammi Vickery; Sherri Davies; Christiane Fauron; Xiaping He; Zhiyuan Hu; John F Quackenbush; Inge J Stijleman; Juan Palazzo; J S Marron; Andrew B Nobel; Elaine Mardis; Torsten O Nielsen; Matthew J Ellis; Charles M Perou; Philip S Bernard
Journal:  J Clin Oncol       Date:  2009-02-09       Impact factor: 44.544

Review 9.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

10.  Comprehensive molecular portraits of human breast tumours.

Authors: 
Journal:  Nature       Date:  2012-09-23       Impact factor: 49.962

View more
  7 in total

1.  Computational disease progression modeling can provide insights into cancer evolution.

Authors:  Steve Goodison; Mark E Sherman; Yijun Sun
Journal:  Oncoscience       Date:  2020-05-01

Review 2.  The In Vivo Selection Method in Breast Cancer Metastasis.

Authors:  Jun Nakayama; Yuxuan Han; Yuka Kuroiwa; Kazushi Azuma; Yusuke Yamamoto; Kentaro Semba
Journal:  Int J Mol Sci       Date:  2021-02-14       Impact factor: 5.923

3.  Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics.

Authors:  Allen Li; Jamie M Keck; Swapnil Parmar; Janice Patterson; Marilyne Labrie; Allison L Creason; Brett E Johnson; Molly Downey; George Thomas; Carol Beadling; Laura M Heiser; Annette Kolodzie; Alexander R Guimaraes; Christopher L Corless; Joe W Gray; Gordon B Mills; Raymond C Bergan; Zahi I Mitri
Journal:  NPJ Precis Oncol       Date:  2021-03-26

4.  Cytokines in various molecular subtypes of breast cancer.

Authors:  Alexsander Autenshlyus; Kristina Davletova; Nikolay Varaksin; Igor Marinkin; Vyacheslav Lyakhovich
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

5.  A novel epithelial-mesenchymal transition (EMT)-related gene signature of predictive value for the survival outcomes in lung adenocarcinoma.

Authors:  Yimeng Cui; Xin Wang; Lei Zhang; Wei Liu; Jinfeng Ning; Ruixue Gu; Yaowen Cui; Li Cai; Ying Xing
Journal:  Front Oncol       Date:  2022-09-15       Impact factor: 5.738

6.  Efficacy of Combination Neoadjuvant Chemotherapy and Regional Inductive Moderate Hyperthermia in the Treatment of Patients With Locally Advanced Breast Cancer.

Authors:  Anton Loboda; Ivan Smolanka; Valerii E Orel; Liubov Syvak; Tetiana Golovko; Iryna Dosenko; Andrii Lyashenko; Ivan Smolanka; Olha Dasyukevich; Tetiana Tarasenko; Valerii B Orel; Alex Rykhalskyi; Oleksandr Ganich; Oleksandr Mokhonko
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

7.  PAM50 Intrinsic Subtype Profiles in Primary and Metastatic Breast Cancer Show a Significant Shift toward More Aggressive Subtypes with Prognostic Implications.

Authors:  Charlotte Levin Tykjær Jørgensen; Anna-Maria Larsson; Carina Forsare; Kristina Aaltonen; Sara Jansson; Rachel Bradshaw; Pär-Ola Bendahl; Lisa Rydén
Journal:  Cancers (Basel)       Date:  2021-03-30       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.